Skip to main content
. 2023 Jul 28;14:1215407. doi: 10.3389/fendo.2023.1215407

Table 4.

Double diabetes status (DDiabOB or DDiabIR) as a diagnostic test for selected maternal or neonatal complications.

Outcome Sensitivity Specificity PPV NPV AUC (95%CI) Accuracy
DDiabOB eGWG 34.3 97.8 81.8 83.7 0.66 (0.62; 0.70) 83.6
DDiabIR eGWG 42.7 80/3 38.4 80.3 0.61 (0.56; 0.66) 71.8
DDiabOB PET 25.0 95.4 7.9 97.3 0.58 (0.53; 0.62) 88.3
DDiabIR PET 60.0 76.1 7.7 98.3 0.68 (0.63; 0.77) 75.6
DDiabOB Preterm delivery<37 gestational weeks 9.9 90.0 22.4 77.4 0.50 (0.45; 0.54) 71.8
DDiabIR Preterm delivery<37 gestational weeks 35.5 77.8 31.9 80.5 0.57 (0.52; 0.62) 68.3
DDiabOB Congenital malformation 10.5 90.5 15.8 85.6 0.50 (0.45; 0.56) 78.9
DDiabIR Congenital malformation 42.5 74.4 22.0 88.4 0.58 (0.53; 0.64) 69.8
DDiabOB NICU hospitalization 9.8 90.4 21.0 79.2 0.50 (0.45; 0.55) 73.6
DDiabIR NICU hospitalization 41.2 76.3 31.4 83.2 0.59 (0.53; 0.64) 69.1
DDiabOB Perinatal mortality 0.0 89.9 0.0 98.7 0.45 (0.40; 0.49) 88.8
DDiabIR Perinatal mortality 50.0 75.2 2.4 99.2 0.63 (0.58; 0.67) 74.9

eGWG, excessive maternal gestational weight gain; NICU, neonatal intensive care unit; NPV, negative predictive value; PET, preeclampsia; PPV, positive predictive value.